Literature DB >> 1597836

Liver and biliary problems in cystic fibrosis.

M S Tanner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1597836      PMCID： PMC1295449     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  30 in total

1.  Prevalence of liver disease in cystic fibrosis.

Authors:  R Scott-Jupp; M Lama; M S Tanner
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

2.  Liver transplantation in cystic fibrosis.

Authors:  L A Mieles; D Orenstein; L Teperman; L Podesta; B Koneru; T E Starzl
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

3.  In vivo bile acid uptake from terminal ileum in cystic fibrosis.

Authors:  G N Thompson; G P Davidson
Journal:  Pediatr Res       Date:  1988-03       Impact factor: 3.756

4.  Liver disease and bile duct abnormalities in adults with cystic fibrosis.

Authors:  R A Nagel; D Westaby; A Javaid; J Kavani; H B Meire; M G Lombard; A Wise; R Williams; M E Hodson
Journal:  Lancet       Date:  1989-12-16       Impact factor: 79.321

5.  Liver disease and common-bile-duct stenosis in cystic fibrosis.

Authors:  K J Gaskin; D L Waters; R Howman-Giles; M de Silva; J W Earl; H C Martin; A E Kan; J M Brown; S F Dorney
Journal:  N Engl J Med       Date:  1988-02-11       Impact factor: 91.245

6.  Portal venous blood flow in cystic fibrosis: assessment by Duplex Doppler sonography.

Authors:  K A Vergesslich; M Götz; G Mostbeck; G Sommer; W Ponhold
Journal:  Pediatr Radiol       Date:  1989

7.  Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.

Authors:  D Gleeson; D C Ruppin; A Saunders; G M Murphy; R H Dowling
Journal:  Q J Med       Date:  1990-07

8.  Excessive fecal taurine loss predisposes to taurine deficiency in cystic fibrosis.

Authors:  G N Thompson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

9.  ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates.

Authors:  T Ishikawa; M Müller; C Klünemann; T Schaub; D Keppler
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

10.  Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis.

Authors:  C Maurage; C Lenaerts; A Weber; P Brochu; I Yousef; C C Roy
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-07       Impact factor: 2.839
View more
  5 in total

Review 1.  Liver disease in cystic fibrosis.

Authors:  M S Tanner; C J Taylor
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

Review 2.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; N Barnes; N Jamieson; P Friend; R Calne
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

3.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; J Valente; N D Barnes; P J Friend; N V Jamieson; A Rasmussen; R Y Calne
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

Review 4.  Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.

Authors:  K Cheng; D Ashby; R Smyth
Journal:  J R Soc Med       Date:  1997       Impact factor: 18.000

Review 5.  Ursodeoxycholic acid for cystic fibrosis-related liver disease.

Authors:  Katharine Cheng; Deborah Ashby; Rosalind L Smyth
Journal:  Cochrane Database Syst Rev       Date:  2017-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.